As opposed to taking a small molecule or even antibody approach to treating neurological disease, Neurona "is focused on unique compositions of cells that can be precisely targeted, integrated into damaged neural circuits, and provide activity-dependent regulation."
A UCSF spinout is growing neuronal stem cells to transplant into the brain, for potential use in treating epilepsy, spinal cord injury, Parkinson’s and Alzheimer’s disease – and investors are listening. Because one thing that differentiates Neurona Therapeutics is that its stem cells turn exclusively into interneuron cells – which are less likely to be tumorigenic than other IPS cells. […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.